Article thumbnail

Neuroprotective Effect of Hyperbaric Oxygen Therapy on Anterior Ischemic Optic Neuropathy

By Bat-Chen R. Avraham-Lubin, Olga Dratviman-Storobinsky, Shimrit Dadon-Bar El, Murat Hasanreisoglu and Nitza Goldenberg-Cohen


The study investigated the therapeutic effect of hyperbaric oxygen (HBO) on anterior ischemic optic neuropathy in a rodent model (rAION). rAION was laser-induced in one eye of 63 mice. The fellow (uninjured) eye served as an internal control. Thirty-three mice underwent two 90-min sessions of 100% oxygen (2 atm) treatment immediately following injury and one session daily thereafter for up to 14 days. The remaining mice were untreated. Retinas were harvested at different time points, and mRNA levels of various genes were analyzed by real-time polymerase chain reaction and histologic study. Untreated mice: day 1 post-rAION – SOD-1 (oxidative-stress-related) decreased to 82% of control (uninjured eye) levels (P < 0.05), Caspase-3 (proapoptotic) decreased to 89%, Bcl-xL mildly increased (117%; all NS); day 3 – HO-1 and endothelial nitric oxide synthase (eNOS; ischaemia-related) decreased to 74%, and Bcl-2-associated X protein, Caspase-3, and B-cell lymphoma 2 (Bcl-2; apoptotic) increased by 170, 120, and 111%, respectively (all NS); day 21 – HO-1 increased to 222% (NS) and eNOS decreased to 48% (P < 0.05). Treated mice: day 1 – SOD-1 and Caspase-3 remained unchanged, Bcl-2 and Bcl-xL mildly increased (112 and 126% respectively); day 3 – HO-1 and eNOS increased, apoptosis-related gene decreased; day 21 – SOD-1 decreased whereas eNOS increased (P < 0.05), and HO-1 increased to a lesser degree than without treatment. None of the oxygen-treated animals had retinal ganglion cell loss or a decrease in Thy-1 expression. In conclusion, HBO treatment after rAION induction influences the expression of apoptosis-related genes as well as oxidative-stress-induced and ischaemia-related genes and may exert a neuroprotective effect

Topics: Neurology
Publisher: Frontiers Research Foundation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2008). A primate model of nonarteritic anterior ischemic optic neuropathy.
  2. (1997). A rat model of chronic pressure-induced opticnervedamage.Exp.EyeRes.64,
  3. (2001). An overview of real-time quantitative PCR: applications to quantify cytokine gene expression.
  4. and Schwaninger,M.(2005).Hyperbaric oxygen reduces blood–brain barrier damage and oedema after transient focal cerebral ischaemia.
  5. (1999). Apoptotic DNA fragmentation and upregulation of Bax induced by transient ischaemia of the rat retina. Brain Res.
  6. (1999). Caspase inhibitors block the retinal ganglion celldeathfollowingopticnervetransection.BrainRes.Mol.BrainRes.67,
  7. (1992). Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I. Ganglion cell layer and inner nuclear layer.
  8. Danesh-Meyer,H.V.(2008).Radiationinduced optic neuropathy.
  9. (2001). Early hyperbaric oxygen therapy for retinal artery occlusion.
  10. (2007). Effect of different periods of hyperbaric oxygen on ischaemia-reperfusion injury of rat skeletal muscle.
  11. (2004). Effects of the hyperbaric oxygen treatment on the Na+,K +-ATPase and superoxide dismutase activities in the optic nerves of global cerebral ischaemia-exposed rats.
  12. (2007). Effectsof hyperbaricoxygentherapy ontheratintestinalmucosaapoptosis caused by ischaemia-reperfusion injury.
  13. (2007). Endothelial-neutrophil interactions during ischaemia and reperfusion injury: basic mechanisms of hyperbaric oxygen.
  14. (2003). Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy.
  15. (2004). Heme oxygenase-1 induced in muller cells plays a protective role in retinal ischaemia-reperfusion injury in rats.
  16. (1996). High intraocular pressure-induced ischaemia and reperfusion injury in the optic nerve and retina in rats.
  17. (2007). Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs.
  18. (2009). Hyperbaric oxygen preconditioning reduces ischaemia-reperfusion injury by inhibition of apoptosis via mitochondrial pathway in rat brain.
  19. (2008). Hyperbaric oxygen therapy and the eye. Undersea Hyperb.
  20. (2007). Hyperbaric oxygen therapy attenuates renal ischaemia/reperfusioninjuryinrats.
  21. (2006). Hyperbaric oxygen therapy for radiation-induced optic neuropathy.
  22. (2004). Hyperbaric oxygen treatment: the influence on the hippocampal superoxide dismutase and Na+,K +-ATPase activities in global cerebral ischaemia-exposed rats.
  23. (2006). Hyperbaric oxygen: a novel technology for modulating myocardial schemia-reperfusion via asingledrug.Adv.Ther.23,528–533.
  24. (1995). Hyperbaric oxygenation therapy for ischemic optic neuropathy.
  25. (2006). Hyperoxic and hyperbaric-induced cardioprotection:roleof nitricoxide s ynthase 3.
  26. (2003). Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model.
  27. (1994). Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils.
  28. (1999). Intrinsic survival mechanisms for retinal ganglion cells.Eur.J.Ophthalmol.9(Suppl.1),
  29. J.,andSchorderet,D.F.(2009).Retinal ischaemia-induced apoptosis is associated with alteration in Bax and Bcl-x(L) expression rather than modificationsinBakandBcl-2.Mol.
  30. (2000). Management of the criticallyillpatientinthehyperbaric chamber.
  31. (2010). Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerve.
  32. (2008). Molecular and histological changes following central retinal artery occlusion in a mouse model.
  33. (2003). Multipleorganpathology,metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1−/− mice.
  34. (2008). Neuroprotection by oxygen in acute transient focal cerebral ischaemia is dose dependent and shows superiority of hyperbaric oxygenation.
  35. (2011). Neuroprotective effect of hyperbaric oxygen therapy on anterior ischemic optic neuropathy.
  36. (2005). Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischaemia.
  37. (2006). Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease.
  38. (2009). Possible neuroprotective effect of brimonidine in a mouse model of ischemic optic neuropathy.
  39. (1996). Protection of retinal ganglion cells from naturalandaxotomy-inducedcelldeath in neonatal transgenic mice overexpressing bcl-2.
  40. (2000). Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model.
  41. (2005). Retinal disease in mice lacking hypoxia-inducible transcription factor-2alpha.
  42. (1996). Retinal ganglion cell death after different transient periods of pressureinduced ischaemia and survival intervals. A quantitative in vivo study.
  43. (2003). Retinal ganglion cells and neuroprotection for glaucoma.
  44. (1994). SOD-1 transgenic mice as a model for studies of neuroprotection in stroke and brain trauma.
  45. (2011). Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  46. (2005). Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1 alpha expression after transient focal cerebral ischaemia.
  47. (2007). The effect of oxygen therapy on brain damage and cerebralpO(2)intransientfocalcerebral ischaemia in the rat.
  48. (2008). The use of hyperbaric oxygen therapy in ophthalmology.
  49. (2002). Treatment of ischemic optic neuropathy.
  50. (2011). Up-regulation of Bax protein in